Wu H - Search Results

1

FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor.

Sun Q, Novak D, Hüser L, Poelchen J, Wu H, Granados K, Federico A, Liu K, Steinfass T, Vierthaler M, Umansky V, Utikal J. Sun Q, et al. Among authors: wu h. Int J Cancer. 2021 Aug 1;149(3):657-674. doi: 10.1002/ijc.33591. Epub 2021 May 6. Int J Cancer. 2021. PMID: 33837564

2

Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.

Wu H, Larribère L, Sun Q, Novak D, Sachindra S, Granados K, Umansky V, Utikal J. Wu H, et al. Int J Cancer. 2018 Dec 1;143(11):2962-2972. doi: 10.1002/ijc.31799. Epub 2018 Sep 29. Int J Cancer. 2018. PMID: 30110134

3

TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.

Weina K, Wu H, Knappe N, Orouji E, Novak D, Bernhardt M, Hüser L, Larribère L, Umansky V, Gebhardt C, Utikal J. Weina K, et al. Among authors: wu h. Pigment Cell Melanoma Res. 2016 Jul;29(4):453-8. doi: 10.1111/pcmr.12483. Pigment Cell Melanoma Res. 2016. PMID: 27105574

4

New role of ID3 in melanoma adaptive drug-resistance.

Sachindra, Larribère L, Novak D, Wu H, Hüser L, Granados K, Orouji E, Utikal J. Sachindra, et al. Among authors: wu h. Oncotarget. 2017 Nov 27;8(66):110166-110175. doi: 10.18632/oncotarget.22698. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299138 Free PMC article.

5

NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model.

Larribere L, Wu H, Novak D, Galach M, Bernhardt M, Orouji E, Weina K, Knappe N, Sachpekidis C, Umansky L, Beckhove P, Umansky V, De Schepper S, Kaufmann D, Ballotti R, Bertolotto C, Utikal J. Larribere L, et al. Among authors: wu h. Pigment Cell Melanoma Res. 2015 Jul;28(4):407-16. doi: 10.1111/pcmr.12369. Epub 2015 Apr 22. Pigment Cell Melanoma Res. 2015. PMID: 25824590

6

Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis.

Jäger K, Larribère L, Wu H, Weiss C, Gebhardt C, Utikal J. Jäger K, et al. Among authors: wu h. Cancers (Basel). 2019 Jan 11;11(1):76. doi: 10.3390/cancers11010076. Cancers (Basel). 2019. PMID: 30641895 Free PMC article.

7

Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance.

Wu H, Huang J. Wu H, et al. Protein Pept Lett. 2018;25(6):514-521. doi: 10.2174/0929866525666180530122835. Protein Pept Lett. 2018. PMID: 29848260 Review.

8

Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies.

Wu H, Huang J. Wu H, et al. Curr Drug Metab. 2018;19(7):559-567. doi: 10.2174/1389200218666171108154419. Curr Drug Metab. 2018. PMID: 29119923 Review.

9

PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging.

Wu H, Huang J. Wu H, et al. Curr Protein Pept Sci. 2016;17(6):582-95. doi: 10.2174/1389203717666160101123832. Curr Protein Pept Sci. 2016. PMID: 26721403 Review.

10

Immunomodulatory Therapies for Renal Cell Carcinoma.

Liu M, Wu H, Shangguan D, Jiang Y, Li X, Liu S, Zhou B, Yin T, Gong Z. Liu M, et al. Among authors: wu h. Protein Pept Lett. 2018;25(6):534-547. doi: 10.2174/0929866525666180531080118. Protein Pept Lett. 2018. PMID: 29848257 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,119 results

Search Page

Filters